Influenza News and Research

Latest Influenza News and Research

New therapy developed for flu infections may also prove effective against HIV, COVID-19

A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists.

24 Nov 2020

Study: Aprotinin can inhibit virus replication by preventing SARS-CoV2 entry into host cells

The surface of the SARS-CoV-2 virus is studded with spike proteins. The virus needs these in order to dock onto proteins (ACE2 receptors) on the surface of the host cell.

24 Nov 2020

Thromboembolism in COVID-19 patients associated with higher risk of mortality

While respiratory issues continue to be the most common symptom of a COVID-19 infection, new research indicates the disease could also be associated with hypercoagulability, or increased tendency of the blood to clot.

23 Nov 2020

Scientists studying aerodynamics of infectious disease reveal ways to reduce indoor SARS-CoV-2 transmission

At the 73rd Annual Meeting of the American Physical Society's Division of the Americal Physical Society's Division of Fluid Dynamics, researchers presented a range of studies investigating the aerodynamics of infectious disease.

23 Nov 2020

FDA expands approved indication for influenza treatment to include post-exposure prevention

Today, the U.S. Food and Drug Administration expanded the approved indication for Xofluza (baloxavir marboxil) to include post-exposure prevention of influenza (flu) for patients 12 years of age and older after contact with an individual who has the flu.

23 Nov 2020

How COVID-19 compares to other respiratory illnesses

A team of scientists from Israel and the United States has compared the disease presentation and progression between in-hospital patients with coronavirus disease 2019 (COVID-19) and other respiratory illnesses such as influenza.

23 Nov 2020

SARS-CoV-2 spike deletion mutations may evade current vaccine candidates, study finds

A thought-provoking new study reports that the anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibodies elicited by natural infection may not be able to neutralize emerging strains that display deletion mutations in their genomic RNA.

23 Nov 2020

Study suggests neutralizing SARS-CoV-2 antibodies offer protection against reinfection

A new study published in November 2020 on the preprint server medRxiv* indicates that the chances of symptomatic infection are indeed much lower among the population with antibodies to the virus.

22 Nov 2020

Pomegranate peel extract shows potential as inhibitor of SARS-CoV-2 virus

Researchers led by first author Relja Suručić from the Department of Pharmacognosy, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina, have studied the use of pomegranate peel extracts in preventing infections with SARS-CoV-2.

22 Nov 2020

SARS-CoV-2 transmission model predicts when schools can be safely reopened

Can schools safely remain open or reopen during periods of significant community spread of COVID-19? According to predictions from a model of SARS-CoV-2 transmission in the school setting, yes - if appropriate precautions are followed both in school and in the community.

20 Nov 2020

High cost of drugs could lead to more than 1.1 million deaths among Medicare recipients

More than 1.1 million Medicare patients could die over the next decade because they cannot afford to pay for their prescription medications, according to a new study released today by the West Health Policy Center, a nonprofit and nonpartisan policy research group and Xcenda, the research arm of the drug distributor AmerisourceBergen.

19 Nov 2020

Swiss data shows COVID-19 three times more deadly than the flu

Despite this, COVID-19 is often downplayed to be only a seasonal flu by many. This may be because both influenza and COVID-19 have a similar initial presentation, and it is tough to distinguish between the two based on just the clinical presentation.

19 Nov 2020

Carrageenan-based composite nasal spray may help prevent SARS-CoV-2 infection

A team of researchers at the University of Birmingham in the United Kingdom formulated a spray that contains polysaccharides known for their mucoadhesive antiviral properties for prophylaxis against SARS-CoV-2 infection.

19 Nov 2020

How the influenza virus takes control of a city, and implications for SARS-CoV-2

SARS-CoV-2 has spread around the world, passed across the borders of nations by travelers and cargo.

19 Nov 2020

Triple RNA sequencing dissects gene expression of virus and fungi in infection processes

Organ and stem cell transplants are proven and frequently used methods in everyday modern clinical practice. However, even when performed regularly in specialized centers, some patients still experience a number of serious complications afterward.

19 Nov 2020

Machine learning can fill significant gap in Canadian public health data

Machine learning can be used to fill a significant gap in Canadian public health data related to ethnicity and Aboriginal status, according to research published today in PLOS ONE by a University of Alberta research epidemiologist.

19 Nov 2020

SARS-CoV-2 deactivation on surfaces in 30 seconds with a copper paste

In a recent bioRxiv preprint paper, a team of researchers shows the possibility of using copper, in a new conformation, for effectively killing microbes immediately.

18 Nov 2020

Optimizing SARS-COV-2 inactivation for COVID-19 research at lower biosafety levels

Researchers at Montana State University have validated and compared two methods for inactivating the causative agent of coronavirus disease 2019 (COVID-19) that would enable the virus to be studied at a lower biosafety level (BSL) than the one currently required.

18 Nov 2020

Study could lead to a new approach for tracking vaccine safety

Vaccines are one of society's greatest success stories, but like any treatment, there can be rare adverse events and they must be tested carefully.

18 Nov 2020

SARS-CoV-2 causes a unique cytokine storm, study finds

A new study published on the preprint server medRxiv* in November 2020 reports some of the unique elements of COVID-19-induced CRS and how understanding these distinctive characteristics of the disease could help in formulating specific interventions and therapies.

18 Nov 2020

Influenza News and Research

Latest Influenza News and Research

New therapy developed for flu infections may also prove effective against HIV, COVID-19

Study: Aprotinin can inhibit virus replication by preventing SARS-CoV2 entry into host cells

Thromboembolism in COVID-19 patients associated with higher risk of mortality

Scientists studying aerodynamics of infectious disease reveal ways to reduce indoor SARS-CoV-2 transmission

FDA expands approved indication for influenza treatment to include post-exposure prevention

How COVID-19 compares to other respiratory illnesses

SARS-CoV-2 spike deletion mutations may evade current vaccine candidates, study finds

Study suggests neutralizing SARS-CoV-2 antibodies offer protection against reinfection

Pomegranate peel extract shows potential as inhibitor of SARS-CoV-2 virus

SARS-CoV-2 transmission model predicts when schools can be safely reopened

High cost of drugs could lead to more than 1.1 million deaths among Medicare recipients

Swiss data shows COVID-19 three times more deadly than the flu

Carrageenan-based composite nasal spray may help prevent SARS-CoV-2 infection

How the influenza virus takes control of a city, and implications for SARS-CoV-2

Triple RNA sequencing dissects gene expression of virus and fungi in infection processes

Machine learning can fill significant gap in Canadian public health data

SARS-CoV-2 deactivation on surfaces in 30 seconds with a copper paste

Optimizing SARS-COV-2 inactivation for COVID-19 research at lower biosafety levels

Study could lead to a new approach for tracking vaccine safety

SARS-CoV-2 causes a unique cytokine storm, study finds

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Influenza News and Research

Latest Influenza News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in